Medicines of botanical origin for the treatment of addictions

NFL Biosciences develops botanical medicines for the treatment of addictions, with the goal of eventually partnering them with pharmaceutical companies

bt_bb_section_bottom_section_coverage_image

Rethinking the treatment of nicotine addiction

Our expertise

Focus on the 3 most common addictive substances, which are frequently present at the same time

https://www.nflbiosciences.com/wp-content/uploads/2023/05/pawel-czerwinski-7USMFYqt1NI-unsplash-1.jpg

Tobacco

https://www.nflbiosciences.com/wp-content/uploads/2023/05/julia-kicova-CXZUyCQjxAk-unsplash-1.jpg

Alcohol

https://www.nflbiosciences.com/wp-content/uploads/2023/05/paul-einerhand-39F7_IfT-r0-unsplash-1.jpg

Cannabis

Revolutionizing withdrawal treatments

NFL-101 & NFL-102: An innovative drug candidate for smoking cessation derived from a nicotine-free tobacco leaf protein extract

NFL-101

NFL-102

NFL 301: A drug candidate to combat excessive alcohol consumption from a traditional Chinese medicine plant

NFL-301

NFL BIOSCIENCES KEY FIGURES

2021

Initial Public Offering

m€ raised on Euronext Growth

clinical studies on NFL-101

clinical study on NFL-102 in progress

An outsourced scientific research company with low operating costs

PRECLINICAL AND CLINICAL STUDIES

HIGH ENVIRONMENTAL IMPACT APPROACH

SEVERAL SCIENTIFIC AWARDS

GLOBAL SCIENTIFIC EXPERTISE IN BOTANICAL MEDICINES

5 PATENT FAMILIES

MANUFACTURING IN FRANCE AND RESPECT FOR BPF

PIPELINE